Szent-Györgyi Prize Archives - Page 5 of 6 - NFCR

Szent-Györgyi Prize

Peter Vogt: The Game Changer

The term “game changer” didn’t come into English usage until 1993, and since then it has been driven into the ground from overuse. But when applied to Peter Vogt, Ph.D., it is more than just hyperbole or overzealous marketing. When you are talking about the person that identified src, the…...

Read more

Frederick Alt: It’s Personal

Ask 100 physicians why they got into medicine and you’ll get 100 different answers: Some take the noble route and want to help people, others are just hardwired for it and still others learned early on that potential mates tend to worship doctors (or at least their mothers do!). And…...

Read more

Dr. Michael Hall on Why Funding is So Important for Cancer Research

Dr. Hall and many other scientist’s innovative research would not be possible without support and funding from private foundations such as the National Foundation for Cancer Research. See why Dr. Hall believes funding plays such an important role in cancer research....

Read more

Harold Dvorak: The Trailblazer

“Tumors are wounds that don’t heal,” says Harold Dvorak, M.D., and if that sounds like an overly simplification, it is a foregone conclusion that some of the most complicated problems have very simple beginnings. A scientists funded by the National Foundation for Cancer Research (NFCR) from 1980 to 2016, Dr.…...

Read more

An Evening Honoring Tremendous Achievement in Cancer Prevention

The National Foundation for Cancer Research’s (NFCR) annual marquee event was held in Washington, DC on Saturday evening, May 5th. The 2018 Szent-Györgyi Prize for Progress in Cancer Research ceremony and dinner occasioned much, including a gathering of NFCR principals and scientists, communication of the Foundation’s mandate, messages from the…...

Read more

Douglas Lowy & John Schiller: An Ounce of Prevention

When Douglas R. Lowy, M.D., and John T. Schiller, Ph.D., receive the 2018 Albert Szent-Györgyi Prize for Cancer Research, it will set a precedent for the honor itself. By creating an effective vaccine for the human papillomavirus (HPV), cause of practically all cervical tumors, Lowy and Schiller forged a means…...

Read more

Michael Hall: TOR de Force

The discovery of rapamycin in 1972 did not create major waves in the oncology community. But in 1989, Michael N. Hall, Ph.D., took a second look, screening yeast cells for rapamycin resistance. That led to the discovery of TOR, or “Target of Rapamycin,” and one of the most profound paradigm…...

Read more

Duo of Oncology Vaccine Pioneers at the National Cancer Institute to Receive 2018 Annual Szent-Györgyi Prize for Progress in Cancer Research

  FOR IMMEDIATE RELEASE: February 15, 2018 CONTACT: Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org First Occasion for Award to Recognize Extraordinary Contributions in Cancer Prevention, Role of Vaccines BETHESDA, MD – The National Foundation for Cancer Research (NFCR) announced today that the 2018 Szent-Györgyi Prize…...

Read more

The Full Story of Dr. Albert Szent-Györgyi

Learn about the Vitamin-C studying, Nobel-Prize winning co-founder of the National Foundation for Cancer Research, Dr. Albert Szent-Györgyi....

Read more